SI-BONE, Inc. (SIBN)
21.48
-0.08
(-0.37%)
USD |
NASDAQ |
Oct 23, 16:00
21.48
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Enterprise Value : 856.95M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 856.95M |
| October 22, 2026 | 860.53M |
| October 21, 2026 | 827.45M |
| October 20, 2026 | 814.93M |
| October 19, 2026 | 775.60M |
| October 16, 2026 | 776.49M |
| October 15, 2026 | 786.78M |
| October 14, 2026 | 767.11M |
| October 13, 2026 | 776.49M |
| October 12, 2026 | 795.27M |
| October 09, 2026 | 762.64M |
| October 08, 2026 | 739.84M |
| October 07, 2026 | 750.57M |
| October 06, 2026 | 770.68M |
| October 05, 2026 | 782.31M |
| October 02, 2026 | 704.98M |
| October 01, 2026 | 719.73M |
| September 30, 2026 | 737.16M |
| September 29, 2026 | 752.81M |
| September 28, 2026 | 735.37M |
| September 25, 2026 | 727.77M |
| September 24, 2026 | 724.65M |
| September 23, 2026 | 728.22M |
| September 22, 2026 | 737.61M |
| September 21, 2026 | 721.52M |
| Date | Value |
|---|---|
| September 18, 2026 | 705.43M |
| September 17, 2026 | 703.19M |
| September 16, 2026 | 725.54M |
| September 15, 2026 | 725.99M |
| September 14, 2026 | 732.69M |
| September 11, 2026 | 718.39M |
| September 10, 2026 | 714.81M |
| September 09, 2026 | 719.73M |
| September 08, 2026 | 729.12M |
| September 04, 2026 | 723.75M |
| September 03, 2026 | 730.01M |
| September 02, 2026 | 753.25M |
| September 01, 2026 | 742.52M |
| August 31, 2026 | 746.99M |
| August 28, 2026 | 755.49M |
| August 27, 2026 | 755.04M |
| August 26, 2026 | 765.32M |
| August 25, 2026 | 770.24M |
| August 24, 2026 | 767.11M |
| August 21, 2026 | 789.01M |
| August 20, 2026 | 767.56M |
| August 19, 2026 | 786.78M |
| August 18, 2026 | 752.36M |
| August 17, 2026 | 732.24M |
| August 14, 2026 | 742.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
| Baxter International, Inc. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.088M |
| Revenue (Quarterly) | 56.01M |
| Total Expenses (Quarterly) | 60.10M |
| EPS Diluted (Quarterly) | -0.0919 |
| Gross Profit Margin (Quarterly) | 79.54% |
| Profit Margin (Quarterly) | -7.30% |
| Earnings Yield | -1.56% |
| Normalized Earnings Yield | -1.555 |